LifeStance Health Group, Inc. (LFST) Misses Q3 EPS by 11c

LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q3 EPS of ($0.35), $0.11 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $173.8 million versus the consensus estimate of $171.36 million.

GUIDANCE:

LifeStance Health Group, Inc. sees FY2021 revenue of $668-678 million, versus the consensus of $670 million.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Navan, Inc. (NAVN) Tops Q2 EPS by 1c, Offers Guidance
• Core & Main, Inc (CNM) Tops Q3 EPS by 2c ; Offers Guidance